AMA confronts the rise of nootropics

| 3 Min Read

Responding to the safety concerns generated by a growing personal use of nootropics, physicians at the Annual Meeting of the American Medical Association (AMA) today adopted new policy discouraging the nonmedical use of prescription drugs for cognitive enhancement in healthy individuals.

Nootropics – the so-called smart drugs – include a variety of prescription drugs, supplements, or other substances that claim to improve cognitive functions of healthy individuals, particularly executive function, memory, learning or intelligence.

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Patient speaks with healthcare worker

Patients don’t have right to ambient AI recordings, court says

| 5 Min Read
Outline of a human heart

Ethical questions about health AI? The AMA has guidance

| 6 Min Read
Physician holds stethoscope

Overlooked well-being factors that could affect your next job

| 6 Min Read
Faceless woman

10 women physicians making their mark on medicine

| 6 Min Read